Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research focused on Apatinib and Cancer, with related work in Cholesterol 7 alpha-hydroxylase, Circulating tumor cell, Randomized controlled trial. Notable publications include 'Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis', 'Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer', and 'Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial'.
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer
Efficacy, Safety, and Immunogenicity of HLX04Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatmentfor Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase IIIStudy
A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression
Safety of apatinib as third-line or beyond treatment in advanced or metastatic gastric cancer: Results from a multicenter phase IV study (Ahead-G201).
Development of non-hematological adverse events in apatinib-treated gastric cancer and their association with clinical outcome: Results from a phase IV study.
BMI differences for clinical outcome in patients with advanced or metastatic gastric cancer treated with apatinib: Data from a post-marketing phase IV study (Ahead-G201).
Impact of time to progression on first-line therapy on clinical outcomes in advanced gastric cancer treated with apatinib: data from a phase IV study (Ahead-G201).
Clinical benefit of continuing apatinib beyond progression in advanced or metastatic gastric cancer.
Response to apatinib by the number of metastatic organs in patients with advanced or metastatic gastric cancer: Subgroup analysis from a phase IV study (Ahead-G201).
Effect of ECOG PS on outcome of advanced or metastatic gastric patients treated with apatinib: Analysis from a post-marketing phase IV study.
Does hypertension history in patients with advanced gastric cancer has an impact on clinical outcomes following apatinib treatment? A subgroup analysis based on data from Ahead-G201 study.
Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis